Suppr超能文献

自身吞噬的自我抑制:“自身标志物”CD47 对 SIRPα 的亲和力决定了抑制的效力,但仅在低表达水平下如此。

Self inhibition of phagocytosis: the affinity of 'marker of self' CD47 for SIRPalpha dictates potency of inhibition but only at low expression levels.

机构信息

Biophysical Engineering Lab, University of Pennsylvania, Philadelphia, PA 19104, USA.

出版信息

Blood Cells Mol Dis. 2010 Jun 15;45(1):67-74. doi: 10.1016/j.bcmd.2010.02.016. Epub 2010 Mar 17.

Abstract

Phagocytes engulf foreign cells but not 'self' in part because self cells express CD47 as a ligand for signal regulatory protein SIRPalpha, which inhibits phagocytosis. Motivated by reports of upregulation of CD47 on both normal and cancerous stem cells [1: Jaiswal et al., 2009] and also by polymorphisms in SIRPalpha [2: Takenaka et al., 2007], we show here that inhibition of engulfment correlates with affinity of CD47 for SIRPalpha - but only at low levels of CD47. One common human polymorph of SIRPalpha is studied and binds more strongly to human-CD47 than to mouse-CD47 (K(d) approximately 0.12 microM and 6.9 microM, respectively) and does not bind sheep red blood cells (RBCs) - which are well-established targets of human macrophages; in comparison, a common mouse polymorph of SIRPalpha binds with similar affinity to human and mouse CD47 (K(d) approximately 0.22 microM). Using immunoglobulin (IgG)-opsonized particles with varying levels of either human- or mouse-CD47, the effective inhibition constants K(i) for blocking phagocytosis are then determined with both human- and mouse-derived macrophages. Only human phagocytes show significant differences in man versus mouse K(i)'s and only at CD47 levels below normal densities for RBCs. While phospho-signaling through human-SIRPalpha shows similar trends, consistent again with the affinity differences, saturating levels of CD47 (>K(i)) can signal and inhibit phagocytosis regardless of man versus mouse. Quantitative analyses here prompt more complete characterizations of both CD47 levels and SIRPalpha polymorphisms when attempting to study in vivo effects of these key proteins in innate immunity.

摘要

吞噬细胞吞噬外来细胞,但不会吞噬“自身”细胞,部分原因是自身细胞表达 CD47 作为信号调节蛋白 SIRPα的配体,从而抑制吞噬作用。受正常和癌细胞干细胞中 CD47 上调的报道[1:Jaiswal 等人,2009]以及 SIRPα多态性的报道[2:Takenaka 等人,2007]的启发,我们在这里表明,吞噬作用的抑制与 CD47 与 SIRPα的亲和力相关-但仅在 CD47 低水平时相关。研究了 SIRPα的一种常见人类多态性,它与人-CD47 的结合比与鼠-CD47 的结合更强(Kd 分别约为 0.12µM 和 6.9µM),并且不结合绵羊红细胞(RBC)-这是人类巨噬细胞的既定靶标;相比之下,常见的鼠 SIRPα多态性与人 CD47 和鼠 CD47 的结合具有相似的亲和力(Kd 约为 0.22µM)。使用具有不同水平人源或鼠源 CD47 的免疫球蛋白(IgG)包被颗粒,然后用源自人源和鼠源的巨噬细胞来确定阻断吞噬作用的有效抑制常数 K i。只有人源吞噬细胞在人与鼠 K i之间存在显著差异,并且仅在 CD47 水平低于 RBC 的正常密度时才存在差异。虽然通过人源 SIRPα的磷酸化信号显示出相似的趋势,这再次与亲和力差异一致,但无论人源还是鼠源,只要 CD47 水平超过(K i),就可以发出信号并抑制吞噬作用。这里的定量分析提示,在试图研究这些先天免疫关键蛋白在体内的作用时,需要更全面地描述 CD47 水平和 SIRPα多态性。

相似文献

5
CD47 functions as a molecular switch for erythrocyte phagocytosis.CD47 作为红细胞吞噬作用的分子开关。
Blood. 2012 Jun 7;119(23):5512-21. doi: 10.1182/blood-2011-10-386805. Epub 2012 Mar 16.
7
Cancer immunotherapy targeting the CD47/SIRPα axis.靶向CD47/SIRPα轴的癌症免疫疗法。
Eur J Cancer. 2017 May;76:100-109. doi: 10.1016/j.ejca.2017.02.013. Epub 2017 Mar 10.

引用本文的文献

9
Cell membrane-coated nanomaterials for cancer therapy.用于癌症治疗的细胞膜包覆纳米材料。
Mater Today Bio. 2023 Apr 12;20:100633. doi: 10.1016/j.mtbio.2023.100633. eCollection 2023 Jun.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验